Research Topics
Genomes and Genes
| Susan L SlagerSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Epidemiol Biomarkers Prev 22:461-6. 2013..These results were further supported by a recent meta-analysis of our GWAS with two other GWAS of CLL, supporting the IRF8 gene as a strong candidate for CLL risk...
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypesSusan L Slager
Mayo Clinic College of Medicine, Rochester, MN, USA
Br J Haematol 159:572-6. 2012..These variants also showed a trend towards association with some of the other NHL subtypes. Our results validate the prior work and support specific genetic pathways for risk among NHL subtypes...
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Blood 120:843-6. 2012..This finding provides additional support for polygenic inheritance to CLL and provides further insight into the biologic basis of disease development...
Susceptibility genes and B-chronic lymphocytic leukaemiaSusan L Slager
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA
Br J Haematol 139:762-71. 2007..The challenge of future studies of this type will be overcoming study design issues, including definition of CLL, sample size limitations and multiple testing issues...
Genome-wide linkage analysis of systolic blood pressure: a comparison of two approaches to phenotype definitionSusan L Slager
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
BMC Genet 4:S13. 2003..For each approach, multipoint linkage analysis was performed using the residuals and the SOLAR computer program. Our results show little difference between the methods based on the LOD scores...
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLSusan L Slager
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Blood 117:1911-6. 2011..Our findings support the hypothesis that familial CLL cases have additional genetic variants not seen in sporadic CLL. Additional loci among familial CLL cases may be identified through larger studies...
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics ProjectSusan L Slager
Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Prostate 66:173-9. 2006..One measure of disease severity is the Gleason score. Using the Gleason score as a measure of tumor aggressiveness, several independent genome scans have reported evidence of linkage. As of yet, however, no genes have been implicated...
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trendS L Slager
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Hum Hered 52:149-53. 2001..The formulas make no assumptions about Hardy-Weinberg equilibrium, but do assume random ascertainment of cases and controls, all of whom are independent of one another. We demonstrate the accuracy of the formulas by simulations...
Evaluation of candidate genes in case-control studies: a statistical method to account for related subjectsS L Slager
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA
Am J Hum Genet 68:1457-62. 2001..An application of our method, to family data from a prostate cancer study, is presented to illustrate the method's utility...
Stoppage: an issue for segregation analysisS L Slager
Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York, NY, USA
Genet Epidemiol 20:328-39. 2001..In conclusion, stoppage, a realistic scenario for some complex diseases, can represent a serious and potentially intractable problem for segregation analysis...
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Cancer Epidemiol Biomarkers Prev 19:1098-102. 2010..A recent genome-wide association study of CLL identified seven genetic variants that increased the risk of CLL within a European population...
Power comparisons between the TDT and two likelihood-based methodsS L Slager
Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA
Genet Epidemiol 20:192-209. 2001..The LOD score provides the lowest power in the presence of LD for the range of GRR considered here...
Candidate-gene association studies with pedigree data: controlling for environmental covariatesS L Slager
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905 USA
Genet Epidemiol 24:273-83. 2003..We also find GEE to fail at least 5% of the time for each simulation configuration; at times, the failure rate reaches above 80%. In summary, our robust method may be the only current regression analysis method available for MCC data...
Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health StudyAnthony A Razzak
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Nutr Cancer 64:899-910. 2012..These data provide minimal support for major effects from the examined micronutrients on overall or molecularly defined CRC risks in the IWHS cohort...
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Cancer Epidemiol Biomarkers Prev 17:3161-9. 2008....
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older womenDavid Limsui
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
Gut 61:1299-305. 2012..Postmenopausal hormone (PMH) therapy may reduce colorectal cancer (CRC) risk, but existing data are inconclusive...
Risk of non-Hodgkin lymphoma in association with germline variation in complement genesJames R Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Br J Haematol 145:614-23. 2009..015; OR = 0.68; 95% 0.56-0.84) remained noteworthy. Associations were similar for the common NHL subtypes. In summary, we provide evidence for a role of genetic variation in complement genes, particularly C5 and C9, and NHL risk...
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcomeTait D Shanafelt
Mayo Clinic, Rochester, MN, USA
Blood 113:4188-96. 2009..Using clinically relevant criteria to distinguish between monoclonal B-cell lymphocytosis (MBL) and CLL could minimize patient distress caused by labeling asymptomatic people at low risk for adverse clinical consequences as having CLL...
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patientsStephen M Ansell
Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Hematol 87:865-9. 2012..99, P = 0.009, overall survival-HR 1.93, P = 0.021). Elevated pretreatment serum IP-10 levels are therefore associated with an increased likelihood of disease relapse and an inferior survival in patients with DLBCL...
Investigation of polymorphisms in the CREM gene in panic disorderSteven P Hamilton
Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
Am J Med Genet B Neuropsychiatr Genet 126:111-5. 2004..These findings provide little additional evidence for a susceptibility locus for panic disorder either within the CREM gene or in a nearby region of chromosome 10p11 in our sample...
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Leuk Lymphoma 51:1233-40. 2010..The in vitro observation that statins reduce rituximab efficacy does not appear to have clinical significance in CLL care...
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly
School of Medicine and Dentistry, University of Rochester, NY, USA
Cancer Causes Control 23:1017-29. 2012....
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of genderJennifer L Kelly
School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
Ann Epidemiol 22:855-62. 2012..To evaluate the association of body mass index (BMI) and physical activity (PA) during adulthood and at the age of 18 years with risk of non-Hodgkin lymphoma (NHL)...
Cigarette smoking and colorectal cancer risk by KRAS mutation status among older womenN J Samadder
Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
Am J Gastroenterol 107:782-9. 2012..In this study, we evaluated associations between cigarette smoking and CRC risk stratified by KRAS mutation status, using data and tissue resources from the Iowa Women's Health Study (IWHS)...
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer Epidemiol Biomarkers Prev 21:1799-806. 2012..Non-Hodgkin lymphoma (NHL) is a malignancy of lymphocytes, and there is growing evidence for a role of germline genetic variation in immune genes in NHL etiology...
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau
Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Hematol 87:880-5. 2012..1, along with C9, were associated with FL EFS after adjusting for clinical variables, and if replicated, these findings add further support for the role of host innate immunity in FL prognosis...
Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older womenAnthony A Razzak
Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Prev Res (Phila) 4:2035-43. 2011..05 for each comparison). These data do not support an adverse effect from alcohol intake on CRC risk, overall or by specific molecularly defined subtypes, among older women...
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Blood 117:1492-8. 2011..47; P = .07). Vitamin D insufficiency is associated with inferior TTT and OS in CLL patients. Whether normalizing vitamin D levels in deficient CLL patients would improve outcome merits clinical testing...
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility LociDaniel J Schaid
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Am J Hum Genet 75:948-65. 2004..The strengths and weaknesses of microsatellite versus SNP markers are illustrated by the results of our genome linkage scans...
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosisClive S Zent
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Leuk Lymphoma 50:1261-8. 2009..We propose that more sensitive and accurate diagnostic methods for CLL have decreased the perceived prevalence of AID cytopenia and that improvements in management could have increased the survival of these patients...
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemiaMatthew J Maurer
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Blood 118:2821-6. 2011..The FLC assay is a simple, widely available clinical test with similar prognostic utility as routinely used prognostic biomarkers for CLL. Among persons with FLC abnormalities, the type of abnormality affects prognostic significance...
Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorderSteven P Hamilton
Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York City, NY 10032, USA
Neuropsychopharmacology 29:558-65. 2004....
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphomaJames R Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Blood 110:4455-63. 2007....
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Cytokine 60:882-9. 2012..Abnormal immune function is a key factor in predisposition to non-Hodgkin lymphoma (NHL). We evaluated the association of 30 cytokines individually and as a profile with diffuse large B-cell (DLBCL) and follicular (FL) lymphomas...
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly
School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA
Cancer Epidemiol Biomarkers Prev 19:2847-58. 2010..In addition, germline variation in both BCL2L11 (BIM) and CASP9, known regulators of apoptosis, has recently been linked to NHL risk. We conducted a comprehensive evaluation of 36 apoptosis pathway genes with risk of NHL...
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneDeborah A Bowen
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Leuk Lymphoma 51:620-7. 2010..No patient required blood cell transfusions after cycle 1 of therapy. We conclude that R-CVP is effective and tolerable therapy for autoimmune cytopenia complicating progressive CLL, but the duration of response is suboptimal...
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemiaTait D Shanafelt
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota 55902, USA
Cancer 116:4777-87. 2010..A study was undertaken to analyze the survival of chronic lymphocytic leukemia (CLL) patients relative to age-matched individuals in the general population and determine the age-stratified utility of prognostic testing...
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt
Mayo Clinic, Rochester, Minnesota 55902, USA
Cancer 118:1827-37. 2012....
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake
College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 28:4191-8. 2010..Recent data also suggest that vitamin D insufficiency is related to inferior prognosis in some cancers, although there are no data for NHL...
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, United States
Leuk Res 33:263-70. 2009..The effectiveness with which physicians help patients adjust to the physical, intellectual, and emotional challenges of CLL appears to impact patient QOL...
Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older womenPaul J Limburg
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Epidemiol Biomarkers Prev 21:681-4. 2012....
Linkage analysis using principal components of gene expression dataElizabeth J Atkinson
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, Minnesota 55905, USA
BMC Proc 1:S79. 2007....
Evaluating the influence of quality control decisions and software algorithms on SNP calling for the affymetrix 6.0 SNP array platformMariza de Andrade
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minn, USA mandrade mayo edu
Hum Hered 71:221-33. 2011..Conclusions: Using our suggested workflow both algorithms performed similarly; however, fewer samples were removed and CRLMM took half the time to run our 854 study samples (4.2 h) compared to Birdseed (8.4 h)...
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphomaAnne J Novak
Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Cancer Res 69:4217-24. 2009..3 ng/mL in those with the high-risk alleles (P = 0.02). Taken together, our data suggest that genetic variation in the TNFSF13B gene is significantly associated with NHL risk and elevated serum BAFF levels...
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entityRoxana S Dronca
Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cytometry B Clin Cytom 78:S35-41. 2010..e. CD5+B-CLPD) are poorly defined...
Mutations in CHEK2 associated with prostate cancer riskXiangyang Dong
Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Mayo Medical School, Rochester, MN 55905, USA
Am J Hum Genet 72:270-80. 2003..Overall, our data suggest that mutations in CHEK2 may contribute to prostate cancer risk and that the DNA-damage-signaling pathway may play an important role in the development of prostate cancer...
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemiaDaniel L Van Dyke
Division of Laboratory Genetics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Br J Haematol 148:544-50. 2010..019). The clinical implications of 13q- in CLL appear more complex than originally appreciated...
Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based studyBenjamin M Solomon
Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
J Clin Oncol 31:930-7. 2013..Chronic lymphocytic leukemia (CLL) is associated with an increased risk of developing second cancers. However, it is unknown whether CLL alters the disease course of these cancers once they occur...
Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphomaShernan G Holtan
Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Cancer 131:1158-68. 2012....
The genetics of gene expression: comparison of linkage scans using two phenotype normalization methodsMariza de Andrade
Division of Biostatistics, Mayo Clinic College of Medicine, 200 First Street Southwest, Harwick 7, Rochester, Minnesota 55905, USA
BMC Proc 1:S151. 2007..In summary, we conclude, as have other published reports, that normalization methods play an important role in the linkage results, and that some significant linkage signals might be due to a specific normalization method...
No association of germline alteration of MSR1 with prostate cancer riskLiang Wang
Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, 920 Hilton Building, Mayo Clinic and Foundation, Rochester, Minnesota, USA
Nat Genet 35:128-9. 2003..Our results do not support MSR1 as a risk factor for prostate cancer...
Cigarette smoking and colorectal cancer risk by molecularly defined subtypesDavid Limsui
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Natl Cancer Inst 102:1012-22. 2010..Because colorectal carcinogenesis is a heterogeneous process, we investigated whether cigarette smoking is differentially associated with molecularly defined subtypes of colorectal cancer...
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphomaKathleen J Yost
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Leuk Lymphoma 54:290-7. 2013..Overall, the FACT-G was a valid measure for monitoring QoL over time in patients with NHL. However, sensitivity analyses based on subscale scoring that excludes potentially problematic items may be warranted...
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, 920 Hilton Building, Rochester, MN 55905, USA
Cancer Epidemiol Biomarkers Prev 18:2492-500. 2009..Finally, these risk alleles do not seem to be associated with survival...
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab eraJames R Cerhan
College of Medicine, Mayo Clinic, Rochester, MN, USA
Leuk Lymphoma 53:1105-12. 2012..In conclusion, germline genetic variation in LMO2 was associated with DLBCL prognosis and provided slightly stronger predictive ability relative to LMO2 IHC status...
Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorderHolly A Garriock
Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
Am J Psychiatry 167:565-73. 2010....
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 27:3959-63. 2009..The natural history of clinically identified MBL is unclear. The goal of this study was to explore the outcome of patients with MBL relative to that of individuals with Rai stage 0 chronic lymphocytic leukemia (CLL)...
Comparison of tagging single-nucleotide polymorphism methods in association analysesEllen L Goode
Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
BMC Proc 1:S6. 2007..e., whether a SNP or haplotype is responsible); unfortunately, this is often unknown at the time of SNP selection. Additional evaluations using empirical and simulated data are needed...
Analysis of the RNASEL gene in familial and sporadic prostate cancerLiang Wang
Department of Laboratory Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Am J Hum Genet 71:116-23. 2002..82; P=.03), as well as in the subset analyses. These results suggest that polymorphic changes within the RNASEL gene may be associated with increased risk of familial but not sporadic PC...
Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab eraGrzegorz S Nowakowski
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 28:412-7. 2010..The clinical impact of statin use on the outcome of lymphoma patients treated with a rituximab-containing regimen is unknown...
Identification of genes involved in alcohol consumption and cigarettes smokingMariza de Andrade
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA
BMC Genet 6:S112. 2005....
Familial chronic lymphocytic leukemia: what does it mean to me?Susan L Slager
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
Clin Lymphoma Myeloma 9:S194-7. 2009..At present it is best to indicate to concerned CLL patients that their relatives are at relatively low risk of developing CLL or other LPDs...
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaClive S Zent
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Br J Haematol 141:615-21. 2008..Revisions of the National Cancer Institute Working Group 96 criteria should consider the aetiology of cytopenia in staging CLL patients...
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisAlbert Gutierrez
Department of Immunology, Mayo Clinic, College of Medicine, Rochester, MN 55905, USA
Blood 116:2975-83. 2010..This study has identified the constitutive activation and prosurvival function of LEF-1 and the Wnt pathway in CLL and uncovered a possible role for these factors in the preleukemic state of monoclonal B-cell lymphocytosis...
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemiaKami Maddocks Christianson
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 139:398-404. 2007..Physicians should strictly adhere to established criteria to initiate treatment for CLL patients who are not participating in clinical trials...
Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22Steven P Hamilton
Department of Psychiatry, College of Physicians and Surgeons at Columbia University, New York, NY, USA
Biol Psychiatry 51:591-601. 2002..CONCLUSIONS: Our findings provide strong evidence for a susceptibility locus for panic disorder either within the COMT gene or in a nearby region of chromosome 22...
Genome scan for linkage to asthma using a linkage disequilibrium-lod score testY Jiang
Department of Statistics and Actuarial Science, 241 Schaeffer Hall, University of Iowa, Iowa City, IA 52242, USA
Genet Epidemiol 21:S303-7. 2001....
Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargementJennifer L St Sauver
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
BJU Int 108:1610-5. 2011....
Markov chain Monte Carlo linkage analysis: effect of bin width on the probability of linkageS L Slager
New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA
Genet Epidemiol 21:S700-5. 2001..We found that bin width, as expected, does affect the max PL and the location estimate, and we recommend that users of Loki explore how their results vary with different bin widths...
Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated moleculesWen Liu Mares
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, Minnesota 55905, USA
BMC Proc 1:S126. 2007..We conclude that variation in the genes encoding p50 and c-Rel may play a role in NF-kappaB-related transcription of FAS, IRF1, and CD40...
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patientsTait D Shanafelt
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 139:255-64. 2007..The effects of CLL on QOL appear to differ from that of other malignancies with a more marked impact on emotional QOL. Research identifying efficacious psycho-oncologic support interventions for patients with CLL is needed...
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand
Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA
J Exp Med 207:2569-79. 2010..Together, these data identify a novel lymphoma-associated mutation in human BAFF-R that results in NF-κB activation and reveals TRAF6 as a necessary component of normal BAFF-R signaling...
Confirmation of linkage of prostate cancer aggressiveness with chromosome 19qS L Slager
Department of Health Sciences Research, Mayo Clinic Foundation, Rochester, MN 55905, USA
Am J Hum Genet 72:759-62. 2003..In addition, we report suggestive evidence for linkage on chromosome 4 (D4S403, P=.00012). The results of previous findings, together with our results, provide strong evidence that chromosome 19 harbors a gene for tumor aggressiveness...
Role of HPC2/ELAC2 in hereditary prostate cancerL Wang
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Cancer Res 61:6494-9. 2001..Cumulatively, these results suggest that alterations within the HPC2/ELAC2 gene play a limited role in genetic susceptibility to HPC...
Effect of allelic heterogeneity on the power of the transmission disequilibrium testS L Slager
Department of Preventive Medicine and Environmental Health, Division of Biostatistics, University of Iowa, Iowa City 52242, USA
Genet Epidemiol 18:143-56. 2000..Thus, the TDT may not be an optimal test in the context of genomic screens under more biologically realistic assumptions...
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myelomaAlexandra J Greenberg
Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
Br J Haematol 157:472-5. 2012..We saw no increased risk in relatives of HC-MGUS probands. We conclude that the prevalence of LC-MGUS is significantly higher among 1° relatives of MM probands compared to the reference population...
Investigation of serotonin-related genes in antidepressant responseE J Peters
Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
Mol Psychiatry 9:879-89. 2004..Intriguingly, we observe that a number of the less frequent alleles of many of the SNP markers were associated with the nonresponse and nonspecific phenotypes...
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II geneZ Deng
Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York, NY, USA
Am J Hum Genet 67:737-44. 2000..These findings indicate that the bone morphogenetic protein-signaling pathway is defective in patients with primary pulmonary hypertension and may implicate the pathway in the nonfamilial forms of the disease...
The IDDM13 region containing the insulin-like growth factor binding protein-5 (IGFBP5) gene on chromosome 2q33-q36 and the genetic susceptibility to rheumatoid arthritisS L Slager
New York Psychiatric Institute, Department of Psychiatry adn Department of Biostatistics, Columbia University College of Physicians and Surgeons, New York, NY, USA
Genes Immun 3:110-3. 2002..These results suggest that, despite the involvement of the 2q33-q36 chromosomal region in another organ-specific autoimmune disease, it is unlikely that this region harbors a RA susceptibility locus...
No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorderS P Hamilton
Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, USA
Mol Psychiatry 6:59-65. 2001..The results reported here provide little support for the role of these polymorphisms in panic disorder...
Analysis of association between the serotonin transporter and antidepressant response in a large clinical sampleJeffrey B Kraft
Department of Psychiatry and Center for Human Genetics, University of California, San Francisco, California 94143 0984, USA
Biol Psychiatry 61:734-42. 2007..We sought to replicate our previous findings that SLC6A4 is associated with response to a selective serotonin reuptake inhibitor (SSRI) in a large case-control study...
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)Sophia S Wang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, MD 20892, USA
Blood 109:3479-88. 2007..0; 95% CI = 1.6-5.6). The pattern of NHL heritability appeared to be uniform across NHL subtypes, but risk patterns differed by specific hematopoietic malignancies and the sex of the relative, revealing critical clues to disease etiology...
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemiaGabrielle S Sellick
Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK
Blood 110:3326-33. 2007..002). None of the regions coincided with areas of common chromosomal abnormalities frequently observed in CLL. These findings provide direct evidence for Mendelian predisposition to CLL and evidence for the location of disease loci...
Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sampleEric J Peters
Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 3:e1872. 2008..We sought to determine whether clinical response or tolerance to the Selective Serotonin Reuptake Inhibitor (SSRI) citalopram is associated with genetic polymorphisms in potentially relevant pharmacokinetic enzymes...
Sequence analysis of the serotonin transporter and associations with antidepressant responseJeffrey B Kraft
Department of Psychiatry and Center for Human Genetics, University of California San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143 0984, USA
Biol Psychiatry 58:374-81. 2005..We sought to test further the hypothesis that SLC6A4 is associated with SSRI response by resequencing this gene in subjects with major depression...
Associations of pacifier use, digit sucking, and child care attendance with cessation of breastfeedingSteven M Levy
Universit of Iowa, Iowa City 52242, USA
J Fam Pract 51:465. 2002..This study assessed the associations between pacifier use, digit sucking, childcare attendance, and breastfeeding cessation among 1387 infants in the Iowa Fluoride Study...
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph ConsortiumEleanor V Willett
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, Heslington, York YO10 5DD, United Kingdom
Int J Cancer 122:2062-70. 2008....
Research Grants
- Statistical Genetic Methods for Cancer Gene StudiesSusan Slager; Fiscal Year: 2006..abstract_text> ..
- Genetic Epidemiology of Chronic Lymphocytic LeukemiaSusan Slager; Fiscal Year: 2007..We expect to identify at least one significant chromosomal region through the linkage analysis conducted in Aim 3. We will then fine map these regions by genotyping additional markers within the regions. ..
- Pooling and expansion of Chronic Lymphocytic Leukemia GWA dataSusan L Slager; Fiscal Year: 2010..Identifying and understanding these genes will inform our limited biology of CLL, as well as improve risk prediction and stratification, and may enable identification of patients who will benefit from early prevention strategies. ..
